As MICs cannot be identified on the basis of universal cancer stem cell markers alone, the analysis of Oct-3/4, SOX2, CD133 and CD24 levels must be associated with behavioral bioassays (spheroid formation, side population cells and ALDH activity), in evaluations of the role of IGF-1 in stemness in melanoma. This evidence concerns the gene IGF1 and melanoma.